Huang Gaobo, Song Weilun, Zhang Yanchao, Ren Bingyi, Lv Yi, Liu Kang
National Local Joint Engineering Research Center for Precision Surgery and Regenerative Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Oncology, Xi'an No.3 Hospital, Xi'an, China.
Front Surg. 2023 Jan 6;9:1025521. doi: 10.3389/fsurg.2022.1025521. eCollection 2022.
Intrahepatic cholangiocarcinoma has an increasing global incidence and mortality rate. Hepatectomy is still the most effective curative treatment for patients with ICC, but the prognosis of patients with ICC is still poor even after curative resection. This study aimed to incorporate important factors obtained from SEER database to construct and validate a nomogram for predicting the cancer-specific survival of patients with ICC after hepatectomy.
We obtained patient data from SEER database. The nomogram was constructed base on six prognostic factors for predicting CSS rates in ICC patients. The nomogram was validated by C-index, ROC curve and calibration curves.
A total of 919 patients with ICC after hepatectomy between 2000 and 2018 were included in this study. A nomogram based on six independent prognostic factors (Black race, AJCC T, AJCC N, AJCC M, chemotherapy and PLNR ≥ 0.15) was developed for the prediction of CSS at 3 and 5 years. The C-index of the nomogram and AJCC stage system were 0.709 and 0.657 in the training cohort respectively. The 3- and 5-year AUCs of nomogram were 0.744 and 0.75 in the training cohort. The calibration plots indicated that there was good agreement between the actual observations and predictions.
In conclusion, we constructed and validated a nomogram for predicting the 3- and 5-year CSS in ICC patients after hepatectomy. We have confirmed the precise calibration and acceptable discrimination power of our nomogram. The predictive power of this nomogram may be improved by considering other potential important factors and also by external validation.
肝内胆管癌在全球的发病率和死亡率呈上升趋势。肝切除术仍是肝内胆管癌患者最有效的根治性治疗方法,但即使进行了根治性切除,肝内胆管癌患者的预后仍然较差。本研究旨在纳入从监测、流行病学与最终结果(SEER)数据库中获得的重要因素,构建并验证一个用于预测肝切除术后肝内胆管癌患者癌症特异性生存的列线图。
我们从SEER数据库中获取患者数据。该列线图基于六个预测肝内胆管癌患者癌症特异性生存(CSS)率的预后因素构建。通过一致性指数(C-index)、受试者工作特征(ROC)曲线和校准曲线对列线图进行验证。
本研究纳入了2000年至2018年间919例肝切除术后的肝内胆管癌患者。基于六个独立预后因素(黑人种族、美国癌症联合委员会(AJCC)肿瘤分期(T)、AJCC淋巴结分期(N)、AJCC远处转移分期(M)、化疗和血小板与淋巴细胞比值(PLNR)≥0.15)开发了一个列线图,用于预测3年和5年的CSS。在训练队列中,列线图和AJCC分期系统的C-index分别为0.709和0.657。列线图在训练队列中的3年和5年曲线下面积(AUC)分别为0.744和0.75。校准图表明实际观察结果与预测结果之间具有良好的一致性。
总之,我们构建并验证了一个用于预测肝切除术后肝内胆管癌患者3年和5年CSS的列线图。我们已经证实了我们列线图的精确校准和可接受的区分能力。通过考虑其他潜在的重要因素以及进行外部验证,该列线图的预测能力可能会得到提高。